The rates of major depressive disorder (MDD) vary from 14.5 to 26.5 percent among adolescents by race and ethnicity, according to a study published online Oct. 9 in JAMA Pediatrics.
Oct 17, 2023
0
4
Patients with schizophrenia have measurable differences in neural and vascular integrity of the retina, according to a study published online March 22 in JAMA Psychiatry.
Apr 20, 2023
0
3
A new study by Jamie Seabrook of Brescia University College and Evan R. Wiley of Western University has shown an alarming number of high school students—26%—in Canada reported having vaped in the previous month. And the ...
Apr 4, 2023
0
19
A study examining the mental health-oral health association cross-sectionally and longitudinally was presented at the 52nd Annual Meeting & Exhibition of the AADOCR, held in conjunction with the 47th Annual Meeting of the ...
Mar 17, 2023
0
40
An analysis of 144 pivotal trials for U.S. Food and Drug Administration (FDA)-approved medications in cancer, cardiovascular disease, and neurology has found that more than half of the studies recruit patients from low- and ...
Nov 22, 2022
0
4
Cross-sectional analysis shows association of reduced kidney function and increased urine albumin excretion with brain volume reduction in regions typically affected by Alzheimer's disease and other dementia etiologies.
Sep 28, 2022
0
8
(HealthDay)—Short-term exposure to air pollution seems to be associated with psoriasis flare, according to a study published online Feb. 16 in JAMA Dermatology.
Feb 16, 2022
0
3
(HealthDay)—The prevalence of depression is increased among pediatric and adult patients with hidradenitis suppurativa (HS), according to a study published in the January issue of the Journal of the American Academy of ...
Jan 12, 2022
0
6
(HealthDay)—There are substantial and increasing disparities in the prevalence of cardiovascular disease (CVD) among the highest-resource group and the remainder of the U.S. population, according to a study published online ...
Sep 30, 2020
0
2
Over the past 2 decades, data submitted to the U.S. Food and Drug Administration (FDA) for new opioid approvals has lacked critical safety and efficacy information. During this timeframe, the FDA approved opioids on the basis ...
Sep 29, 2020
0
2
